Literature DB >> 21718313

Increased interleukin-10 production by ASC-deficient CD4+ T cells impairs bystander T-cell proliferation.

Sharmal Narayan1, Laeticia Kolly, Alexander So, Nathalie Busso.   

Abstract

Apoptosis-associated speck-like protein containing a caspase recruitment domain (ASC) is an important component of the inflammasome, functioning as an adaptor protein that facilitates the recruitment and activation of procaspases that in turn promote the maturation of interleukin-1β (IL-1β) and IL-18. Despite initial focus on the inflammatory properties of ASC there is emerging evidence that highlights the importance of ASC in facilitating adaptive immune responses. However, the cellular and molecular basis for the involvement of ASC in adaptive immunity remains largely unexplored. We have previously demonstrated that activated ASC-deficient T cells have dampened proliferative responses. We have therefore explored the underlying cellular mechanism(s) by which ASC regulates T-cell proliferation. We show that under activating conditions (anti-CD3/CD28 stimulation) in bulk T-cell cultures the presence of ASC(-/-) CD4(+) T cells is sufficient to suppress the proliferative responses of neighbouring T cells. Furthermore, ASC(-/-) CD4(+) T cells upon activation exhibit a suppressive cytokine profile, with elevated production of IL-10 and reduced secretion of T helper type 1 cytokines, interferon-γ and IL-2. This increase in IL-10 secretion within the activated ASC(-/-) CD4(+) T-cell compartment was not associated with a proportional increase in conventional Foxp3(+) regulatory T (Treg) cells. Interestingly, when equal numbers of fluorescence-activated cell sorted ASC(+/+) and ASC(-/-) Treg cells (CD4(+) CD44(intermediate/high) CD25(+)) were activated in vitro, the ASC(-/-) fraction produced significantly more IL-10 than their wild-type counterparts, suggesting that ASC(-/-) Treg cells have greater suppressive capacity. Collectively, these results imply that the ASC may influence the development and functioning of Treg cells.
© 2011 The Authors. Immunology © 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21718313      PMCID: PMC3173692          DOI: 10.1111/j.1365-2567.2011.03462.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  19 in total

1.  Role for IL-10 in suppression mediated by peptide-induced regulatory T cells in vivo.

Authors:  Anette Sundstedt; Emma J O'Neill; Kirsty S Nicolson; David C Wraith
Journal:  J Immunol       Date:  2003-02-01       Impact factor: 5.422

2.  IL-10-secreting regulatory T cells do not express Foxp3 but have comparable regulatory function to naturally occurring CD4+CD25+ regulatory T cells.

Authors:  Pedro L Vieira; Jillian R Christensen; Sophie Minaee; Emma J O'Neill; Franck J Barrat; André Boonstra; Thomas Barthlott; Brigitta Stockinger; David C Wraith; Anne O'Garra
Journal:  J Immunol       Date:  2004-05-15       Impact factor: 5.422

Review 3.  The inflammasome.

Authors:  Virginie Petrilli; Stéphanie Papin; Jürg Tschopp
Journal:  Curr Biol       Date:  2005-08-09       Impact factor: 10.834

4.  Cutting edge: critical role for PYCARD/ASC in the development of experimental autoimmune encephalomyelitis.

Authors:  Patrick J Shaw; John R Lukens; Samir Burns; Hongbo Chi; Maureen A McGargill; Thirumala-Devi Kanneganti
Journal:  J Immunol       Date:  2010-04-05       Impact factor: 5.422

5.  Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf.

Authors:  Sanjeev Mariathasan; Kim Newton; Denise M Monack; Domagoj Vucic; Dorothy M French; Wyne P Lee; Meron Roose-Girma; Sharon Erickson; Vishva M Dixit
Journal:  Nature       Date:  2004-06-09       Impact factor: 49.962

6.  Apoptosis-associated speck-like protein containing a caspase recruitment domain is a regulator of procaspase-1 activation.

Authors:  Christian Stehlik; Sug Hyung Lee; Andrea Dorfleutner; Angela Stassinopoulos; Junji Sagara; John C Reed
Journal:  J Immunol       Date:  2003-12-01       Impact factor: 5.422

7.  The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta.

Authors:  Fabio Martinon; Kimberly Burns; Jürg Tschopp
Journal:  Mol Cell       Date:  2002-08       Impact factor: 17.970

8.  A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis.

Authors:  H Groux; A O'Garra; M Bigler; M Rouleau; S Antonenko; J E de Vries; M G Roncarolo
Journal:  Nature       Date:  1997-10-16       Impact factor: 49.962

9.  In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines.

Authors:  Franck J Barrat; Daniel J Cua; André Boonstra; David F Richards; Chad Crain; Huub F Savelkoul; René de Waal-Malefyt; Robert L Coffman; Catherine M Hawrylowicz; Anne O'Garra
Journal:  J Exp Med       Date:  2002-03-04       Impact factor: 14.307

10.  Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression.

Authors:  R de Waal Malefyt; J Haanen; H Spits; M G Roncarolo; A te Velde; C Figdor; K Johnson; R Kastelein; H Yssel; J E de Vries
Journal:  J Exp Med       Date:  1991-10-01       Impact factor: 14.307

View more
  10 in total

Review 1.  Molecular regulation of cell fate in cerebral ischemia: role of the inflammasome and connected pathways.

Authors:  George Trendelenburg
Journal:  J Cereb Blood Flow Metab       Date:  2014-09-17       Impact factor: 6.200

Review 2.  Insights into inflammasome regulation: cellular, molecular, and pathogenic control of inflammasome activation.

Authors:  Naveen Challagundla; Bhaskar Saha; Reena Agrawal-Rajput
Journal:  Immunol Res       Date:  2022-05-24       Impact factor: 4.505

3.  Transcriptome analysis of GVHD reveals aurora kinase A as a targetable pathway for disease prevention.

Authors:  Scott N Furlan; Benjamin Watkins; Victor Tkachev; Ryan Flynn; Sarah Cooley; Swetha Ramakrishnan; Karnail Singh; Cindy Giver; Kelly Hamby; Linda Stempora; Aneesah Garrett; Jingyang Chen; Kayla M Betz; Carly G K Ziegler; Gregory K Tharp; Steven E Bosinger; Daniel E L Promislow; Jeffrey S Miller; Edmund K Waller; Bruce R Blazar; Leslie S Kean
Journal:  Sci Transl Med       Date:  2015-11-25       Impact factor: 17.956

4.  A randomized phase 2 trial of idiotype vaccination and adoptive autologous T-cell transfer in patients with multiple myeloma.

Authors:  Muzaffar H Qazilbash; Neeraj Y Saini; Soung-Chul Cha; Zhe Wang; Edward A Stadtmauer; Veerabhadran Baladandayuthapani; Heather Lin; Beryl Tross; Medhavi Honhar; Sheetal S Rao; Kunhwa Kim; Michael Popescu; Szymon Szymura; Tiantian Zhang; Aaron Anderson; Qaiser Bashir; Elizabeth J Shpall; Robert Z Orlowski; Bruce L Levine; Naseem Kerr; Alfred Garfall; Adam Cohen; Dan T Vogl; Karen Dengel; Carl H June; Richard Champlin; Larry W Kwak
Journal:  Blood       Date:  2022-03-03       Impact factor: 22.113

5.  Inflammasome activation is critical to the protective immune response during chemically induced squamous cell carcinoma.

Authors:  Thais Helena Gasparoto; Carine Ervolino de Oliveira; Luisa Thomazini de Freitas; Claudia Ramos Pinheiro; Juliana Issa Hori; Gustavo Pompermaier Garlet; Karen Angélica Cavassani; Roxana Schillaci; João Santana da Silva; Dario Simões Zamboni; Ana Paula Campanelli
Journal:  PLoS One       Date:  2014-09-30       Impact factor: 3.240

6.  CARD-Associated Risk Score Features the Immune Landscape and Predicts the Responsiveness to Anti-PD-1 Therapy in IDH Wild-Type Gliomas.

Authors:  Depei Li; Wanming Hu; Xiaoping Lin; Ji Zhang; Zhenqiang He; Sheng Zhong; Xia Wen; Peiyu Zhang; Xiaobing Jiang; Hao Duan; Chengcheng Guo; Jian Wang; Jing Zeng; Zhongping Chen; Yonggao Mou; Ke Sai
Journal:  Front Cell Dev Biol       Date:  2021-03-19

7.  Absent in Melanoma 2 (AIM2) Regulates the Stability of Regulatory T Cells.

Authors:  Beatriz Lozano-Ruiz; Amalia Tzoumpa; Claudia Martínez-Cardona; David Moreno; Ana M Aransay; Ana R Cortazar; Joanna Picó; Gloria Peiró; Juanjo Lozano; Pedro Zapater; Rubén Francés; José M González-Navajas
Journal:  Int J Mol Sci       Date:  2022-02-17       Impact factor: 5.923

8.  ASC deficiency suppresses proliferation and prevents medulloblastoma incidence.

Authors:  E R W Knight; E Y Patel; C A Flowers; A J Crowther; J P Ting; C R Miller; T R Gershon; M Deshmukh
Journal:  Oncogene       Date:  2014-01-27       Impact factor: 9.867

9.  Changes of CD4(+) CD25(+) Regulatory T Cells, FoxP3 in Adjuvant Arthritis Rats with Damage of Pulmonary Function and Effects of Tripterygium Glycosides Tablet.

Authors:  Wan Lei; Liu Jian
Journal:  Int J Rheumatol       Date:  2012-12-27

10.  The Inflammasome Adaptor ASC Intrinsically Limits CD4+ T-Cell Proliferation to Help Maintain Intestinal Homeostasis.

Authors:  Hanif Javanmard Khameneh; Keith Weng Kit Leong; Andrea Mencarelli; Maurizio Vacca; Bezaleel Mambwe; Kurt Neo; Alice Tay; Francesca Zolezzi; Bernett Lee; Alessandra Mortellaro
Journal:  Front Immunol       Date:  2019-07-15       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.